Life Sciences Alert: FDA Releases Criteria for Responsible Officer Prosecutions
2/14/2011
After almost a year of making clear its intention to target more individual executives when their companies allegedly violate the Federal Food, Drug, and Cosmetic Act (FDCA), the U.S. Food and Drug Administration (FDA) recently added a new chapter to its Regulatory Procedures Manual, outlining the criteria that it will consider in determining whether to target those individuals.
